DNA Mutations Flashcards

1
Q

Exons and splicing

A

EXON: contain the coding sequence.

If there is alternative splicing different proteins can be made from same gene

Exon shuffling allows new proteins to be made e.g. the immune system
Thus exon shuffling enable huge variants of antibodies etc. to be produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of variant

A

Duplications of genes or part of gene

Deletions (whole gene or some exons)

Variants within the regulatory sequence

Splice site variants

Introduce premature stop codon-nonsense variant

Replace one amino acid in protein with another – mis-sense variant

Expansion of trinucleotide repeats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Out of frame Deletions

A

Clearly disrupts the protein

e.g.deletion causing absence of dystrophin in DMD

e.g. deletion causing the absence of dystrophin in duchenne muscular dystrophy. If C is lost, the sequence shifts to the right once meaning the reading frame of the
ATC GTT TAC GCG
gene is changed. Can cause quite catastrophic effects - early mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In frame deletions

A

In frame deletion in dystrophin truncated protein causing milder Becker Muscular dystrophy

In frame deletion leads to a complete codon is removed thus only one amino acid is lost. This ATC GTC TTA GCG is less catastrophic. Known as in frame deletion since the reading frame is not altered. Results is a milder disease - later onset death typically
ATC GTC GCG TGC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Splice-Site Variant

A

Affects the accurate removal of an intron

  • Enzyme recognises CGAT as cutting site, A changes to C and then enzyme no longer recognises the sequence so excision does not occur thus sequence of intron is translated and proteins are synthesised.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-sense variant/mutation

A

• Change codon to stop codon

• Out of frame deletion produces a stop codon either at deletion site or further along
-results in an incomplete, usually non-functional protein. E.g. Duchenne’s muscular dystrophy

• RNA detaches from the ribosome and is eliminated

This process is called Nonsense mediated decay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mis-sense variant/mutation

A

• Single base substitution

• Changes the type of amino acid in the protein

• May or may not be pathogenic (cause disease)

• May be a polymorphism of no functional significance

This can have a varied affect and can result in a silent mutation and a non functional protein E.g Sickle cell disease where CAG was replaced with CTG. May or may not be pathogenic could be a polymorphism or of no functional significance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Expansion of a tri-nucleotide repeat

A

Huntington’s disease CAG

  • Triple repeat is repeated several times in the first part of the coding sequence
  • The normal range of repeats is 15-20
  • If the repeats are larger than 36, the patient will develop Huntington’s, if repeats
    number is larger than 36 then onset of disease will be earlier. If repeats are less than 36 than no disease

Myotonic dystrophy CTG

Fragile X CGG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anticipation

A

repeat gets bigger when transmitted to the next generation and so symptoms develop earlier and are more severe

Example; muscle dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Heterogeneity

A

One gene, one variant, one disease e.g. Huntingtons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALLELIC HETEROGENEITY

A

Lots of different variants in one gene e.g. cystic fibrosis

Can give rise to different clinical conditions- genotype/phenotype correlations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

LOCUS HETEROGENEITY

A

Variants in different genes give the same clinical condition e.g. hypertrophic cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dominant variants

A

manifest the disease phenotype in the heterozygous state i.e. the condition occurs if there is one variant and one normal allele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Recessive variants

A

only manifest the disease in the homozygous state i.e. there have to be variants in both alleles. The majority of pathogenic variants are recessive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mechanisms of Dominance

A

Loss-of-function variants

Gain of Function variants

Dominant-negative variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Loss-of-function variants

A

Only one allele functioning. Most loss of
function variants are recessive

If a pathway is very sensitive to the amount of
gene product so that if only half is produced it cannot function this will cause a problem

Haplo-insufficiency

17
Q

Gain of Function variants

A

Increased gene dosage e.g. PMP22 duplication on 1 allele in hereditary motor and sensory neuropathy type 1A

Increased protein activity e.g. a variant may occur at the recognition site for protein degradation leading to an accumulation of undegraded protein within the cell

18
Q

Dominant-negative variants

A

Where the protein from the variant allele interferes with the protein from the normal allele.

E.g. a dimer where one variant and one normal allele would result in only 25% normal dimers

19
Q

Genetic Test Depends on Clinical Context

A

• Diagnostic
• Predictive
• Carrier
• Pre-natal
• Preimplantation genetic diagnosis
• Screening
• Susceptibility

20
Q

Diagnostic test

A

• Patient has signs and symptoms suggesting a particular diagnosis

• A molecular genetic test will confirm a diagnosis

• In this context a genetic test is being used to confirm a clinical diagnosis

• Issues informed consent

21
Q

Predictive testing

A

• Testing health at-risk family members for a previously identified familial variant – often dominant

• HD No intervention

• BRCA1/2 some intervention

22
Q

Carrier testing

A

• Autosomal recessive and X-linked disorder

• Testing an individual in isolation not particularly helpful – couple testing

• Reproductive decision making

23
Q

Pre-natal test

A

• Genetic test performed in pregnancy where there is a increased risk of a specific condition affecting the fetus

• Chorionic villous sample or amniocentesis

• Often chromosomal or DNA if specific variant in the family has been identified

• Counselling issues

24
Q

PGD

Pre-implantation Genetic Diagnosis

A

8 cell embryo

Under gentle suction pipettes removes one cell

Single cell free for analysis

25
Q

Genetic screening

A

• Target population, not high risk families

• E.g. Newborn screening for Cystic fibrosis

• It may be the same test but the context is different

26
Q

Susceptibility testing

A

• Increased or decreased risk for a multifactorial condition

• This issue is only just emerging

27
Q

Types of codons

A

Start- AUG

Stop- UGA, UAG, UAA

28
Q

DNA mutation- duplication

A

• Duplications of genes or part of a gene (of a single base or whole gene)

29
Q

DNA repair issues

A

Base or nucleotide excision, mismatch repair or transcription- coupled repair